Versant Ventures overview
Versant Ventures contact information
Offices
One Sansome Street, Suite 1650, San Francisco, 94104, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Steve Edelson | Job titleVice President, Investor Relations and Communications | LocationSan Francisco, United States | Email  ------- |
| Mr. Max Eisenberg | Job titleChief Operating Officer and General Counsel | LocationSan Francisco, United States | Email ------ |
| Mr. Richard Van Doren | Job titleChief Financial Officer | LocationSan Francisco, United States | Email --------- |
| Mr. Brian Atwood | Job titleManaging Director | LocationSan Francisco, United States | Email ----------- |
Versant Ventures funds managed
Closed funds: 15
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size -------- | Close dateApr 2023 | Strategy ------- | |
Fund size ------- | Close dateApr 2023 | Strategy ---------- | |
Fund size ------ | Close dateApr 2023 | Strategy -------- | |
Stories that mention Versant Ventures
Side Letter: VC giants fall flat
Before we get to today's Side Letter, the big news overnight, of course, was Donald Trump's victory over Kamala Harris, and the Republicans winning back control of the Senate. Private equity, for all the scrutiny it has come under in recent years, hasn't been a major battleground in this election. If you'd like to share your thoughts on this morning's results – anonymously or otherwise – we'd love to hear from you. In the meantime, here's today's brief, for our valued subscribers only.
IMRF confirms $85m in commitments
The US public pension has backed four venture capital funds in its latest round of commitments.
Canadian VC market gets a boost in 2016
It reached new records in terms of funds raised and money invested that were not seen since the dot-com era.
Lone Star-backed Del Frisco’s pulls $100m IPO
The steakhouse operator, acquired as part of the $600m take-private of Lone Star Steakhouse & Saloon in 2006, cited ‘current public market conditions’ in its filing with the SEC.
Versant raises $500m for Fund IV
The California-based firm, which invests in seed and early stage healthcare companies, has brought its capital under management to a total of $1.6bn with the closure of its fourth fund after two months in the market.
Deal round-up
Mowbray launches European venture FoF; Apatech raises £6.5 million in Series B financing; KKR leads $250m pharma round; ARCH Venture closes $350m Fund VI;
KKR leads $250m pharma round
Jazz Pharmaceuticals snags one of the largest second round financings on record for a speciality pharma company without any commercialized drugs.
Deal round-up 29/10/03
European investors back US nanotech round; Apax leads Wisair round; ePlanet Ventures invests in End2End; Bumper round for Biospect